What Punto Health does

Punto Health is a London-based healthtech company founded in 2023 that builds an AI-powered cognitive care platform targeting Alzheimer's disease and other dementias. The platform consists of three integrated products: PuntoCare, a smartphone and tablet application offering personalised daily plans (cognitive, physical, and nutrition activities), clinically validated educational content, an AI assistant for tips and strategies, and a cognitive and behavioural symptom registry; PuntoTest, an evidence-based cognitive assessment tool that uses speech-based digital biomarkers for early detection and remote monitoring of cognitive change, trained on clinical cohorts including SMC, MCI, and dementia patients; and PuntoClinic, a clinical dashboard for healthcare providers to monitor patient progress, conduct remote pre-screening, generate shareable reports, and select patients for clinical trials. The platform serves three customer segments: individuals (patients, carers, and active seniors), healthcare providers (hospitals, clinics, and clinicians), and home care organisations, addressing fragmented dementia care, lack of continuous personalised support between clinical visits, caregiver burden, and the need for scalable cognitive assessment in healthcare systems.

The underlying technology is grounded in proprietary speech-based digital biomarker models co-designed with Ace Alzheimer Center Barcelona, a recommendation engine that tailors daily care plans to each user's stage of cognitive decline, and a generative AI assistant that delivers personalised tips and strategies. The platform has been clinically piloted with 2,000+ cognitive tests performed, 60,000+ exercises completed by users, and an 88.7% customer satisfaction score, and has reached 1,500+ participants through pilots across NHS services (Oxleas NHS Foundation Trust), Spanish hospitals (Hospital del Mar Barcelona, Hospital General de Granollers), and pharmacies. The platform is GDPR-compliant and is delivered through both mobile app stores for consumer access and direct B2B sales to healthcare providers.

Punto Health operates a hybrid go-to-market motion combining B2B enterprise sales to healthcare providers and health systems with B2C self-serve distribution through the PuntoCare consumer app. Revenue is generated via SaaS subscriptions to healthcare providers for PuntoClinic (likely tiered by patient volume or features) and potential freemium or subscription models on the PuntoCare consumer app, although pricing is not publicly disclosed. Distribution channels include NHS and hospital partnerships, pharmacy distribution (piloted in Spain), and mobile app stores, with geographic focus on the UK and Spain. The company has raised approximately €645,000 in pre-seed funding (May 2024), an additional £550K in pre-seed, a €100,000 NN Social Innovation Startup Award grant (2025), and a $2.7 million Seed round (December 2025) co-led by Shilling VC and Plus Partners, and participates in Google for Startups Accelerator 2025, Startup Health, Barcelona Health Hub, Digital Health London, and the Alzheimer's Society Launchpad Incubator 2026.

Name

Punto Health

Legal name

Punto Health

Website

https://puntohealth.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Punto Health is a London-based healthtech company building an AI-powered cognitive care platform for Alzheimer's and dementia. Its products—PuntoCare, PuntoTest, and PuntoClinic—serve patients, families, healthcare providers, and home care organisations in the UK and Spain.

Ownership category

akta.pro rank

Product category

Digital Health — Cognitive Care Platform

NAICS

Services for the Elderly and Persons with Disabilities (624120)

SIC

Services-Nursing & Personal Care Facilities (8050)

akta.pro primary industry

Memory Care Care Management & Navigation (Dementia Care Coordination) (HLADACAJ)

akta.pro secondary industry

Childcare & Eldercare Caregiving Platforms (BPAMAHAJ)

Keywords

• Cognitive care platform
• Dementia management software
• Digital health solutions
• Speech biomarker assessment
• Clinical decision support

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. SaaS Platform Subscriptions: Punto Health generates revenue through SaaS subscriptions for healthcare providers using PuntoClinic, with pricing likely tiered based on patient volume or feature access. The PuntoCare app may offer freemium or subscription models for individuals and families.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Punto Health operates an AI-powered cognitive care platform for the detection, monitoring, and daily management of Alzheimer's and other dementias. The platform comprises three integrated products: PuntoTest (speech-based digital biomarker assessment for early detection), PuntoCare (mobile app delivering personalised daily care plans for patients and families), and PuntoClinic (clinical dashboard for healthcare providers to monitor patient progress and coordinate care).

Product overview

Punto Health offers a comprehensive AI-powered cognitive care platform consisting of three integrated products: PuntoCare (a mobile app for daily support, personalized care plans, and symptom tracking for patients and families), PuntoTest (a speech-based digital biomarker for early cognitive assessment and monitoring), and PuntoClinic (a clinical dashboard for healthcare providers to remotely assess patients and coordinate with families). The platform is co-designed with Ace Alzheimer Center Barcelona and has been piloted across NHS services, Spanish hospitals, and pharmacies.

Differentiator

Problem solved

Functional benefit

Brands

• PuntoCare: Smartphone/tablet app offering daily support to people with cognitive impairment and their families, featuring personalised daily plans with cognitive, physical, and nutrition activities, clinically validated articles, AI assistant with tips and strategies, and cognitive and behavioural symptom registry.
• PuntoTest
• PuntoClinic

Products and services

• PuntoCare Smartphone/tablet application providing daily support to people with cognitive impairment and their families, featuring personalised daily plans with cognitive, physical, and nutrition activities, clinically validated articles, an AI assistant with tips and strategies, and a cognitive and behavioural symptom registry. Targeted at patients, carers, active seniors, and families managing cognitive decline.
• PuntoTest Evidence-based cognitive assessment tool using speech-based digital biomarkers for early detection and monitoring of cognitive changes. Enables remote monitoring and large-scale pre-screening, with a model trained on clinical cohorts including SMC, MCI, and dementia patients.
• PuntoClinic Clinical platform for healthcare providers to monitor patient progress and collaborate with families. Features cognitive health monitoring tools, remote pre-screening capabilities, shareable reports for ongoing evaluation, and the ability to select patients for clinical trials and new treatments. Designed for integration into existing clinical workflows.

Quantifiable outcome

• 2,000+ cognitive tests performed
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and supporting.

• Ace Alzheimer Center BarcelonacoreStrategic or Co-development Partner · 29 May 2024Clinical collaborator that co-designed the platform with Punto Health. The platform is validated with Ace Alzheimer's clinical data and cohorts. Core strategic partner for clinical validation and product development.
• NHS Oxleas NHS Foundation TrustcoreStrategic or Co-development PartnerNHS trust piloting Punto Health's platform across NHS services, providing real-world clinical validation and feedback for product refinement.
• Hospital del Mar BarcelonacoreStrategic or Co-development PartnerSpanish hospital piloting the platform, contributing to clinical validation and serving as a reference implementation partner in Spain.
• Hospital General De GranollerssupportingStrategic or Co-development PartnerSpanish hospital contributing to pilot programmes, providing additional clinical validation in the Spanish healthcare system.
• Google for Startups Accelerator 2025supportingGTM or Marketing PartnerPunto Health was selected for Google for Startups Accelerator 2025, receiving mentorship, cloud credits, and technical support from Google to scale their technology.
• Startup HealthsupportingGTM or Marketing PartnerHealth innovation ecosystem platform that includes Punto Health, providing visibility and connections within the global health tech community.
• Barcelona Health HubsupportingGTM or Marketing PartnerDigital health innovation hub in Barcelona that Punto Health is part of, providing networking, mentorship, and visibility within the European digital health ecosystem.
• Digital Health LondonsupportingGTM or Marketing PartnerDigital health innovation organization in London that Punto Health is affiliated with, supporting UK market presence and connections.
• Serious Games LabsupportingStrategic or Co-development PartnerResearch lab focused on games for health that Punto Health collaborates with, potentially contributing gamification elements to cognitive exercises.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Linus Health: Digital cognitive health platform offering AI-driven cognitive assessments and brain health tools for early detection of dementia and other neurological conditions. Directly comparable to Punto Health's PuntoTest and PuntoClinic offerings targeting providers and health systems.
• Altoida: AI-based digital biomarker platform for early prediction of Alzheimer's disease using smartphone-based cognitive assessments. Closely comparable to Punto Health's speech-based digital biomarker approach and clinical validation strategy.
• Neurotrack: Digital health company developing cognitive assessment tools and brain health programs for early detection and management of memory impairment, including Alzheimer's. Comparable in combining consumer-facing cognitive tools with provider/clinical programs.
• BrainCheck: Digital cognitive assessment platform used by clinicians to detect, diagnose, and treat cognitive impairment including dementia. Directly comparable clinical workflow positioning to PuntoClinic.

Emerging players

• Isaac Health: Hybrid in-person and virtual memory clinic offering dementia diagnosis, treatment, and care navigation. Comparable in providing end-to-end dementia care management and coordination across the patient journey.
• Darmiyan: AI-based brain health analytics platform using non-invasive imaging and software to detect early signs of Alzheimer's. Comparable AI-driven early detection positioning for dementia.
• C2N Diagnostics: Diagnostics company offering blood-based and digital tools for early detection of Alzheimer's disease and related dementias. Comparable in clinical-grade biomarker approach to early dementia detection.
• Memora Health: AI-powered care coordination platform for complex care journeys. Comparable in delivering AI-driven personalized patient engagement, reminders, and care navigation for chronic and complex care populations.

Broad incumbents

• Biogen: Large biotech company with a leading portfolio in Alzheimer's therapeutics and diagnostics partnerships. Represents the broad incumbent therapeutic/diagnostic ecosystem in which Punto Health's biomarker could be deployed for screening and trial recruitment.
• Roche: Global diagnostics and pharma incumbent with major investments in Alzheimer's diagnostics (e.g., Elecsys amyloid assays). Represents a potential partner or competitor in scaling cognitive biomarker testing across health systems.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/punto-health

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds3 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Punto Health